Filing Details

Accession Number:
0001708138-21-000062
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-19 16:05:05
Reporting Period:
2021-08-18
Accepted Time:
2021-08-19 16:05:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1013064 Roy P Vagelos 777 Old Saw Mill River Road
Tarrytown NY 10591
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-27 22,000 $0.00 327,090 No 5 G Direct
Common Stock Disposition 2021-06-14 19,000 $0.00 308,090 No 5 G Direct
Common Stock Disposition 2021-08-09 17,000 $0.00 291,090 No 5 G Direct
Common Stock Disposition 2021-04-01 446 $0.00 142,350 No 5 G Indirect by CLAT
Common Stock Disposition 2021-07-02 373 $0.00 141,977 No 5 G Indirect by CLAT
Common Stock Disposition 2021-08-18 10,039 $650.04 37,747 No 4 S Indirect by Spouse as Trustee
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 5 G Direct
No 5 G Direct
No 5 G Indirect by CLAT
No 5 G Indirect by CLAT
No 4 S Indirect by Spouse as Trustee
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,218 Indirect By 401(k) Plan
Common Stock 3,609 Indirect by trust for grandch
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 10,039 shares of Company stock on August 18, 2021 at prices ranging from $650.00 to $650.31. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 18, 2021 at each separate price.
  3. By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.